Endoplasmic reticulum retention and prolonged association of a von Willebrand's disease-causing von Willebrand factor variant with ERp57 and calnexin

被引:27
作者
Allen, S
Goodeve, AC
Peake, IR
Daly, ME
机构
[1] Univ Sheffield, Royal Hallamshire Hosp, Sch Med, Div Clin Sci, Sheffield S10 2RX, S Yorkshire, England
[2] Univ Sheffield, Royal Hallamshire Hosp, Div Genom Med, Sheffield S10 2RX, S Yorkshire, England
关键词
von Willebrand factor; von Willebrand's disease; ERp57; calnexin; calreticulin; molecular chaperones; endoplasmic reticulum;
D O I
10.1006/bbrc.2000.4139
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously identified a mutation (R273W) in the von Willebrand factor (VWF) propeptide that results in quantitative deficiency of plasma VWF and a loss of high molecular weight VWF multimers. Recombinant VWF having the R273W mutation (rVWFR273W) expressed in COS-7 cells demonstrated severely impaired secretion and degradation in an intracellular location [Allen, S., et al. (2000) Blood 96, 560-568]. In this report we used pulse-chase analysis and endoglycosidase H digestion of wild-type rVWF and rVWFR273W immunoprecipitated from COS-7 cells to show that rVWFR273W was retained in the endoplasmic reticulum (ER). We demonstrate for the first time that wild-type rVWF and rVWFR273W interacted with the thiol-dependent oxidoreductase ERp57 during biosynthesis in the ER Pulse chase analysis demonstrated that the interactions of rVWFR273W with ERp57 and calnexin were prolonged compared to wild-type rVWF. In contrast there was no apparent difference between rVWFR273W and wild-type rVWF in their time-courses of interaction with calreticulin. (C) 2001 Academic Press.
引用
收藏
页码:448 / 453
页数:6
相关论文
共 21 条
[1]  
Allen S, 2000, BLOOD, V96, P560
[2]   Calnexin and calreticulin bind to enzymically active tissue-type plasminogen activator during biosynthesis and are not required for folding to the native conformation [J].
Allen, S ;
Bulleid, NJ .
BIOCHEMICAL JOURNAL, 1997, 328 :113-119
[3]   Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor [J].
Allen, S ;
Abuzenadah, AM ;
Blagg, JL ;
Hinks, J ;
Nesbitt, IM ;
Goodeve, AC ;
Gursel, T ;
Ingerslev, J ;
Peake, IR ;
Daly, ME .
BLOOD, 2000, 95 (06) :2000-2007
[4]   THE RELATIONSHIP OF N-LINKED GLYCOSYLATION AND HEAVY-CHAIN BINDING-PROTEIN ASSOCIATION WITH THE SECRETION OF GLYCOPROTEINS [J].
DORNER, AJ ;
BOLE, DG ;
KAUFMAN, RJ .
JOURNAL OF CELL BIOLOGY, 1987, 105 (06) :2665-2674
[5]   PROTEIN DISSOCIATION FROM GRP78 AND SECRETION ARE BLOCKED BY DEPLETION OF CELLULAR ATP LEVELS [J].
DORNER, AJ ;
WASLEY, LC ;
KAUFMAN, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) :7429-7432
[6]   Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor [J].
Eikenboom, JCJ ;
Matsushita, T ;
Reitsma, PH ;
Tuley, EA ;
Castaman, G ;
Briet, E ;
Sadler, JE .
BLOOD, 1996, 88 (07) :2433-2441
[7]   Setting the standards: Quality control in the secretory pathway [J].
Ellgaard, L ;
Molinari, M ;
Helenius, A .
SCIENCE, 1999, 286 (5446) :1882-1888
[8]   Analysis of Arg834Gln and Va1902Glu type 2A von Willebrand disease mutations. Studies with recombinant von Willebrand factor and correlation with patient characteristics [J].
Englender, T ;
Lattuada, A ;
Mannucci, PM ;
Sadler, JE ;
Inbal, A .
BLOOD, 1996, 87 (07) :2788-2794
[9]   The role of ERp57 in disulfide bond formation during the assembly of major histocompatibility complex class I in a synchronized semipermeabilized cell translation system [J].
Farmery, MR ;
Allen, S ;
Allen, AJ ;
Bulleid, NJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) :14933-14938
[10]   The protein disulphide-isomerase family:: unravelling a string of folds [J].
Ferrari, DM ;
Söling, HD .
BIOCHEMICAL JOURNAL, 1999, 339 :1-10